Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells

S. Greco, A. Muscella, M. G. Elia, S. Romano, C. Storelli, Santo Marsigliante

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The kinin peptides are released during inflammation and are amongst the most potent known mediators of vasodilatation, pain, and oedema. A role in the modulation or induction of healthy breast tissue growth has been postulated for tissue kallikrein present in human milk. Moreover, tissue kallikrein was found in malignant human breast tissue and bradykinin (BK) stimulates the proliferation of immortalised breast cancer cells. Aim of the present article was to investigate whether BK also exerts mitogenic activity in normal breast epithelial cells and partially characterise the signalling machinery involved. Results show that BK increased up to 2-fold the 24 h proliferation of breast epithelial cells in primary culture, and that the BK B2 receptor (not B1) inhibitor alone fully blocked the BK response. Intracellular effects of B2 stimulation were the following: (a) the increase of free intracellular Ca 2+ concentration by a mechanism dependent upon the phospholipase C (PLC) activity; (b) the cytosol-to-membrane translocation of conventional (PKC)-α and -β isozymes, novel PKC-δ, -ε, and -η isozymes; (c) the phosphorylation of the extracellular-regulated kinase 1 and 2 (ERK1/2); and (d) the stimulation of the expression of c-Fos protein. EGF, a well known stimulator of cell proliferation, regulated the proliferative response in human epithelial breast cells to the same extent of BK. The effects of BK on proliferation, ERK1/2 phosphorylation, and c-Fos expression were abolished by GF109203X., which inhibits PKC-δ isozyme. Conversely, Gö6976, an inhibitor of PKC-α and -β isozymes, and the 18-h treatment of cells with PMA, that led to the complete down-regulation of PKC-α, -β, -ε and -η, but not of PKC-δ, did not have any effect, thereby indicating that the PKC-δ mediates the mitogenic signalling of BK. Phosphoinositide 3-kinase (PI3K), tyrosine kinase of the epidermal growth factor receptor (EGFR), and mitogen activated protein kinase kinases (MEK) inhibitors were also tested. The results suggest that EGFR, PI3K, and ERK are required for the proliferative effects of BK. In addition, the BK induced cytosol-to-membrane translocation of PKC-δ was blocked by PI3K inhibition, suggesting that PI3K is upstream to PKC-δ. In conclusion, BK has mitogenic actions in cultured human epithelial breast cells; the activation of PKC-δ through B2 receptor acts in concert with ERK and PI3K pathways to induce cell proliferation.

Original languageEnglish
Pages (from-to)84-96
Number of pages13
JournalJournal of Cellular Physiology
Volume201
Issue number1
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Bradykinin B2 Receptors
Bradykinin
Breast
Epithelial Cells
1-Phosphatidylinositol 4-Kinase
Phosphatidylinositols
Phosphotransferases
Isoenzymes
Tissue Kallikreins
Phosphorylation
Mitogen-Activated Protein Kinase Kinases
Cell proliferation
Epidermal Growth Factor Receptor
Cytosol
Cells
Cell Proliferation
Tissue
Proto-Oncogene Proteins c-fos
Membranes
Kinins

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Physiology

Cite this

Greco, S., Muscella, A., Elia, M. G., Romano, S., Storelli, C., & Marsigliante, S. (2004). Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. Journal of Cellular Physiology, 201(1), 84-96. https://doi.org/10.1002/jcp.20052

Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. / Greco, S.; Muscella, A.; Elia, M. G.; Romano, S.; Storelli, C.; Marsigliante, Santo.

In: Journal of Cellular Physiology, Vol. 201, No. 1, 10.2004, p. 84-96.

Research output: Contribution to journalArticle

Greco, S, Muscella, A, Elia, MG, Romano, S, Storelli, C & Marsigliante, S 2004, 'Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells', Journal of Cellular Physiology, vol. 201, no. 1, pp. 84-96. https://doi.org/10.1002/jcp.20052
Greco, S. ; Muscella, A. ; Elia, M. G. ; Romano, S. ; Storelli, C. ; Marsigliante, Santo. / Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. In: Journal of Cellular Physiology. 2004 ; Vol. 201, No. 1. pp. 84-96.
@article{4d4459f2024e4d74ac8cb446999ee269,
title = "Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells",
abstract = "The kinin peptides are released during inflammation and are amongst the most potent known mediators of vasodilatation, pain, and oedema. A role in the modulation or induction of healthy breast tissue growth has been postulated for tissue kallikrein present in human milk. Moreover, tissue kallikrein was found in malignant human breast tissue and bradykinin (BK) stimulates the proliferation of immortalised breast cancer cells. Aim of the present article was to investigate whether BK also exerts mitogenic activity in normal breast epithelial cells and partially characterise the signalling machinery involved. Results show that BK increased up to 2-fold the 24 h proliferation of breast epithelial cells in primary culture, and that the BK B2 receptor (not B1) inhibitor alone fully blocked the BK response. Intracellular effects of B2 stimulation were the following: (a) the increase of free intracellular Ca 2+ concentration by a mechanism dependent upon the phospholipase C (PLC) activity; (b) the cytosol-to-membrane translocation of conventional (PKC)-α and -β isozymes, novel PKC-δ, -ε, and -η isozymes; (c) the phosphorylation of the extracellular-regulated kinase 1 and 2 (ERK1/2); and (d) the stimulation of the expression of c-Fos protein. EGF, a well known stimulator of cell proliferation, regulated the proliferative response in human epithelial breast cells to the same extent of BK. The effects of BK on proliferation, ERK1/2 phosphorylation, and c-Fos expression were abolished by GF109203X., which inhibits PKC-δ isozyme. Conversely, G{\"o}6976, an inhibitor of PKC-α and -β isozymes, and the 18-h treatment of cells with PMA, that led to the complete down-regulation of PKC-α, -β, -ε and -η, but not of PKC-δ, did not have any effect, thereby indicating that the PKC-δ mediates the mitogenic signalling of BK. Phosphoinositide 3-kinase (PI3K), tyrosine kinase of the epidermal growth factor receptor (EGFR), and mitogen activated protein kinase kinases (MEK) inhibitors were also tested. The results suggest that EGFR, PI3K, and ERK are required for the proliferative effects of BK. In addition, the BK induced cytosol-to-membrane translocation of PKC-δ was blocked by PI3K inhibition, suggesting that PI3K is upstream to PKC-δ. In conclusion, BK has mitogenic actions in cultured human epithelial breast cells; the activation of PKC-δ through B2 receptor acts in concert with ERK and PI3K pathways to induce cell proliferation.",
author = "S. Greco and A. Muscella and Elia, {M. G.} and S. Romano and C. Storelli and Santo Marsigliante",
year = "2004",
month = "10",
doi = "10.1002/jcp.20052",
language = "English",
volume = "201",
pages = "84--96",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells

AU - Greco, S.

AU - Muscella, A.

AU - Elia, M. G.

AU - Romano, S.

AU - Storelli, C.

AU - Marsigliante, Santo

PY - 2004/10

Y1 - 2004/10

N2 - The kinin peptides are released during inflammation and are amongst the most potent known mediators of vasodilatation, pain, and oedema. A role in the modulation or induction of healthy breast tissue growth has been postulated for tissue kallikrein present in human milk. Moreover, tissue kallikrein was found in malignant human breast tissue and bradykinin (BK) stimulates the proliferation of immortalised breast cancer cells. Aim of the present article was to investigate whether BK also exerts mitogenic activity in normal breast epithelial cells and partially characterise the signalling machinery involved. Results show that BK increased up to 2-fold the 24 h proliferation of breast epithelial cells in primary culture, and that the BK B2 receptor (not B1) inhibitor alone fully blocked the BK response. Intracellular effects of B2 stimulation were the following: (a) the increase of free intracellular Ca 2+ concentration by a mechanism dependent upon the phospholipase C (PLC) activity; (b) the cytosol-to-membrane translocation of conventional (PKC)-α and -β isozymes, novel PKC-δ, -ε, and -η isozymes; (c) the phosphorylation of the extracellular-regulated kinase 1 and 2 (ERK1/2); and (d) the stimulation of the expression of c-Fos protein. EGF, a well known stimulator of cell proliferation, regulated the proliferative response in human epithelial breast cells to the same extent of BK. The effects of BK on proliferation, ERK1/2 phosphorylation, and c-Fos expression were abolished by GF109203X., which inhibits PKC-δ isozyme. Conversely, Gö6976, an inhibitor of PKC-α and -β isozymes, and the 18-h treatment of cells with PMA, that led to the complete down-regulation of PKC-α, -β, -ε and -η, but not of PKC-δ, did not have any effect, thereby indicating that the PKC-δ mediates the mitogenic signalling of BK. Phosphoinositide 3-kinase (PI3K), tyrosine kinase of the epidermal growth factor receptor (EGFR), and mitogen activated protein kinase kinases (MEK) inhibitors were also tested. The results suggest that EGFR, PI3K, and ERK are required for the proliferative effects of BK. In addition, the BK induced cytosol-to-membrane translocation of PKC-δ was blocked by PI3K inhibition, suggesting that PI3K is upstream to PKC-δ. In conclusion, BK has mitogenic actions in cultured human epithelial breast cells; the activation of PKC-δ through B2 receptor acts in concert with ERK and PI3K pathways to induce cell proliferation.

AB - The kinin peptides are released during inflammation and are amongst the most potent known mediators of vasodilatation, pain, and oedema. A role in the modulation or induction of healthy breast tissue growth has been postulated for tissue kallikrein present in human milk. Moreover, tissue kallikrein was found in malignant human breast tissue and bradykinin (BK) stimulates the proliferation of immortalised breast cancer cells. Aim of the present article was to investigate whether BK also exerts mitogenic activity in normal breast epithelial cells and partially characterise the signalling machinery involved. Results show that BK increased up to 2-fold the 24 h proliferation of breast epithelial cells in primary culture, and that the BK B2 receptor (not B1) inhibitor alone fully blocked the BK response. Intracellular effects of B2 stimulation were the following: (a) the increase of free intracellular Ca 2+ concentration by a mechanism dependent upon the phospholipase C (PLC) activity; (b) the cytosol-to-membrane translocation of conventional (PKC)-α and -β isozymes, novel PKC-δ, -ε, and -η isozymes; (c) the phosphorylation of the extracellular-regulated kinase 1 and 2 (ERK1/2); and (d) the stimulation of the expression of c-Fos protein. EGF, a well known stimulator of cell proliferation, regulated the proliferative response in human epithelial breast cells to the same extent of BK. The effects of BK on proliferation, ERK1/2 phosphorylation, and c-Fos expression were abolished by GF109203X., which inhibits PKC-δ isozyme. Conversely, Gö6976, an inhibitor of PKC-α and -β isozymes, and the 18-h treatment of cells with PMA, that led to the complete down-regulation of PKC-α, -β, -ε and -η, but not of PKC-δ, did not have any effect, thereby indicating that the PKC-δ mediates the mitogenic signalling of BK. Phosphoinositide 3-kinase (PI3K), tyrosine kinase of the epidermal growth factor receptor (EGFR), and mitogen activated protein kinase kinases (MEK) inhibitors were also tested. The results suggest that EGFR, PI3K, and ERK are required for the proliferative effects of BK. In addition, the BK induced cytosol-to-membrane translocation of PKC-δ was blocked by PI3K inhibition, suggesting that PI3K is upstream to PKC-δ. In conclusion, BK has mitogenic actions in cultured human epithelial breast cells; the activation of PKC-δ through B2 receptor acts in concert with ERK and PI3K pathways to induce cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=4444339348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444339348&partnerID=8YFLogxK

U2 - 10.1002/jcp.20052

DO - 10.1002/jcp.20052

M3 - Article

C2 - 15281091

AN - SCOPUS:4444339348

VL - 201

SP - 84

EP - 96

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 1

ER -